Innate Pharma S.A. (NASDAQ:IPHA) Q1 2026 Earnings Call Transcript May 13, 2026
Innate Pharma S.A. beats earnings expectations. Reported EPS is $-0.34627, expectations were $-0.34918.
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results. [Operator Instructions] I will now hand the conference over to Stephanie Cornen, Vice President of Investor Relations, Communications and Commercial Strategy at Innate...
